REFERENCES
1 Singer M, Deutschman CS, Seymour CW et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-10.
2 van der Poll T, van de Veerdonk FL, Scicluna BP et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017; 17: 407-20.
3 Reinhart K, Daniels R, Kissoon N et al. Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med 2017;377: 414-7.
4 Stolk RF, van der Pasch E, Naumann F et al. Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis. Am J Respir Crit Care Med 2020; 202: 830-42.
5 Shimaoka T, Kume N, Minami M et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275: 40663–6.
6 Chaparro V, Leroux LP, Zimmermann A et al. Leishmania donovani Lipophosphoglycan Increases Macrophage-Dependent Chemotaxis of CXCR6-Expressing Cells via CXCL16 Induction. Infect Immun 2019; 87: e00064-19.
7 Fahy OL, Townley SL, McColl SR et al. CXCL16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gamma interferon production. Infect Immun 2006; 74: 6885-94.
8 Izquierdo MC, Martin-Cleary C, Fernandez-Fernandez B et al.CXCL16 in kidney and cardiovascular injury. Cytokine Growth Factor Rev 2014; 25: 317-25.
9 Nanki T, Shimaoka T, Hayashida K et al. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2006;54: 765-78.
10 Hassan AM, Farghal NMA, Hegab DS et al. Serum-soluble CXCL16 in juvenile systemic lupus erythematosus: a promising predictor of disease severity and lupus nephritis. Clin Rheumatol 2018; 37:3025-32.
11 Ajona D, Zandueta C, Corrales L et al. Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. Am J Respir Crit Care Med 2018; 197:1164-76.
12 Kim MJ, Sun HJ, Song YS et al. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer. Sci Rep 2019; 9: 13288.
13 Gao Q, Zhao YJ, Wang XY et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res 2012;72: 3546-56.
14 Tu GW, Ju MJ, Zheng YJ et al. CXCL16/CXCR6 is involved in LPS-induced acute lung injury via P38 signalling. J Cell Mol Med2019; 23: 5380-9.
15 Landrø L, Damås JK, Halvorsen B et al. CXCL16 in HIV infection - a link between inflammation and viral replication. Eur J Clin Invest 2009; 39: 1017-24.
16 Lehrke M, Millington SC, Lefterova M et al. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol 2007; 49: 442-9.
17 Smith C, Halvorsen B, Otterdal K et al. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovasc Res 2008; 79: 195-203.
18 Andersen T, Ueland T, Ghukasyan Lakic T et al. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol 2019;39: 2402-10.
19 Song Z, Zhang X, Zhang L et al. Progranulin Plays a Central Role in Host Defense during Sepsis by Promoting Macrophage Recruitment. Am J Respir Crit Care Med 2016; 194: 1219-32.
20 Lin X, Luo H, Yan X, et al . Interleukin-34 Ameliorates Survival and Bacterial Clearance in Polymicrobial Sepsis. Crit Care Med 2018; 46: e584-e90.
21 Yan X, Tu H, Liu Y et al. Interleukin-17D Aggravates Sepsis by Inhibiting Macrophage Phagocytosis. Crit Care Med 2020;48: e58-e65.
22 Uza N, Nakase H, Yamamoto S et al. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. Gut 2011; 60: 1494-505.
23 Jansson AM, Aukrust P, Ueland T et al. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes. Circulation 2009;119: 3181-8.
24 Hoogerwerf JJ, Tanck MWT, Zoelen MAD et al. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med 2010; 36: 630-7.
25 Liu B, Chen YX, Yin Q et al. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care 2013; 17:R244.
26 Demaret J, Villars-Méchin A, Lepape A et al. Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients.Intensive Care Med 2014; 40: 1089-96.
27 Gao X, Liu Y, Xu F et al. Assessment of Apoptosis Inhibitor of Macrophage/CD5L as a Biomarker to Predict Mortality in the Critically Ill With Sepsis. Chest 2019; 156: 696-705.
28 Woehrl B, Klein M, Rupprecht TA et al. CXCL16 contributes to neutrophil recruitment to cerebrospinal fluid in pneumococcal meningitis. J Infect Dis 2010;202: 1389-96.
29 Wehr A, Baeck C, Ulmer F et al. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. PLoS One 2014; 9:e112327.